APA

Rup B., Pallardy M., Sikkema D., Albert T., Allez M., Broet P., Carini C., Creeke P., Davidson J., De Vries N., Finco D., Fogdell-Hahn A., Havrdova E., Hincelin-Mery A., C Holland M., H Jensen P. E., Jury E. C., Kirby H., Kramer D., Lacroix-Desmazes S., Legrand J., Maggi E., Maillère B., Mariette X., Mauri C., Mikol V., Mulleman D., Oldenburg J., Paintaud G., R Pedersen C., Ruperto N., Seitz R., Spindeldreher S. & Deisenhammer F. (20151117). Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium. : Clinical and experimental immunology.

Chicago

Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, Carini C, Creeke P, Davidson J, De Vries N, Finco D, Fogdell-Hahn A, Havrdova E, Hincelin-Mery A, C Holland M, H Jensen P E, Jury E C, Kirby H, Kramer D, Lacroix-Desmazes S, Legrand J, Maggi E, Maillère B, Mariette X, Mauri C, Mikol V, Mulleman D, Oldenburg J, Paintaud G, R Pedersen C, Ruperto N, Seitz R, Spindeldreher S and Deisenhammer F. 20151117. Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium. : Clinical and experimental immunology.

Harvard

Rup B., Pallardy M., Sikkema D., Albert T., Allez M., Broet P., Carini C., Creeke P., Davidson J., De Vries N., Finco D., Fogdell-Hahn A., Havrdova E., Hincelin-Mery A., C Holland M., H Jensen P. E., Jury E. C., Kirby H., Kramer D., Lacroix-Desmazes S., Legrand J., Maggi E., Maillère B., Mariette X., Mauri C., Mikol V., Mulleman D., Oldenburg J., Paintaud G., R Pedersen C., Ruperto N., Seitz R., Spindeldreher S. and Deisenhammer F. (20151117). Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium. : Clinical and experimental immunology.

MLA

Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, Carini C, Creeke P, Davidson J, De Vries N, Finco D, Fogdell-Hahn A, Havrdova E, Hincelin-Mery A, C Holland M, H Jensen P E, Jury E C, Kirby H, Kramer D, Lacroix-Desmazes S, Legrand J, Maggi E, Maillère B, Mariette X, Mauri C, Mikol V, Mulleman D, Oldenburg J, Paintaud G, R Pedersen C, Ruperto N, Seitz R, Spindeldreher S and Deisenhammer F. Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium. : Clinical and experimental immunology. 20151117.